The characteristics of the ICD, such as the exposure of CRT and other ER proteins on the cell surface, the release of HMGB1 or the secretion of ATP, allow for the prediction of the capacity of anti-cancer drugs to stimulate therapeutic immune responses by ICD [265]. Here, CALR is linked to cancer.